An in-depth look to DONGSUN GPHARMACEUTICAL operating, investing, and financing activities

002210 free cash flow for Q3 24 is -2.23 B KRW. For 2023, 002210 free cash flow was -4.89 B KRW and operating cash flow was -4.29 B KRW.